Krista L. Lanctot - Publications

Affiliations: 
Pharmacology and Toxicology University of Toronto, Toronto, ON, Canada 
Area:
Pharmacology, Physiological Psychology

149 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bawa KK, Krance SH, Herrmann N, Cogo-Moreira H, Ouk M, Yu D, Wu CY, Black SE, Lanctôt KL, Swardfager W. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease. Journal of Neuroinflammation. 17: 84. PMID 32171317 DOI: 10.1186/s12974-020-01750-3  1
2019 Kapoor A, Si K, Yu AYX, Lanctot KL, Herrmann N, Murray BJ, Swartz RH. Younger Age and Depressive Symptoms Predict High Risk of Generalized Anxiety After Stroke and Transient Ischemic Attack. Stroke. STROKEAHA119025464. PMID 31405330 DOI: 10.1161/STROKEAHA.119.025464  0.6
2019 Ruthirakuhan MT, Herrmann N, Gallagher D, Andreazza AC, Kiss A, Verhoeff NPLG, Black SE, Lanctôt KL. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial. Contemporary Clinical Trials Communications. 15: 100385. PMID 31338476 DOI: 10.1016/j.conctc.2019.100385  1
2019 Kapoor A, Scott C, Lanctot KL, Herrmann N, Murray BJ, Thorpe KE, Lien K, Sicard M, Swartz RH. Symptoms of depression and cognitive impairment in young adults after stroke/transient ischemic attack. Psychiatry Research. PMID 31272664 DOI: 10.1016/j.psychres.2019.06.022  0.6
2019 Lanctôt KL, Lindsay MP, Smith EE, Sahlas DJ, Foley N, Gubitz G, Austin M, Ball K, Bhogal S, Blake T, Herrmann N, Hogan D, Khan A, Longman S, King A, et al. : Mood, Cognition and Fatigue following Stroke, 6th edition update 2019. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493019847334. PMID 31221036 DOI: 10.1177/1747493019847334  0.6
2019 Khan MM, Lanctôt KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, Gandell D, Brenkel MC, Hazan EL, Docteur NG, Herrmann N. The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clinical Interventions in Aging. 14: 841-848. PMID 31190770 DOI: 10.2147/CIA.S201615  0.6
2019 Mohammad D, Herrmann N, Saleem M, Swartz RH, Oh PI, Bradley J, Chan P, Ellis C, Lanctôt KL. Validity of a novel screen for cognitive impairment and neuropsychiatric symptoms in cardiac rehabilitation. Bmc Geriatrics. 19: 163. PMID 31185923 DOI: 10.1186/s12877-019-1177-0  0.6
2019 Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctôt KL. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31182351 DOI: 10.1016/j.jagp.2019.05.002  1
2019 Eakin KA, Saleem M, Herrmann N, Cogo-Moreira H, Mielke MM, Oh PI, Haughey NJ, Venkata SLV, Lanctôt KL, Swardfager W. Plasma Sphingolipids Mediate a Relationship Between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise. Journal of Alzheimer's Disease : Jad. PMID 31006687 DOI: 10.3233/JAD-181203  0.6
2019 Ahmed M, Malik M, Teselink J, Lanctôt KL, Herrmann N. Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia. Drugs & Aging. PMID 30957198 DOI: 10.1007/s40266-019-00668-7  0.6
2019 Ruthirakuhan M, Herrmann N, Vieira D, Gallagher D, Lanctôt KL. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30910421 DOI: 10.1016/j.jagp.2019.02.003  0.6
2019 Darwish L, Nguyen MM, Saleem M, Eakin KA, Herrmann N, Sugamori KS, Oh PI, Yang P, Mitchell J, Lanctôt KL, Swardfager W. Lower serum osteocalcin concentrations in patients with type 2 diabetes and relationships with vascular risk factors among patients with coronary artery disease. Journal of Diabetes and Its Complications. PMID 30799280 DOI: 10.1016/j.jdiacomp.2019.01.003  0.6
2019 Kapoor A, Lanctot KL, Bayley M, Herrmann N, Murray BJ, Swartz RH. Screening for Post-Stroke Depression and Cognitive Impairment at Baseline Predicts Long-Term Patient-Centered Outcomes After Stroke. Journal of Geriatric Psychiatry and Neurology. 32: 40-48. PMID 30793663 DOI: 10.1177/0891988718819859  0.6
2019 Paes B, Kim D, Saleem M, Wong S, Mitchell I, Lanctot KL. Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders. European Journal of Pediatrics. PMID 30610419 DOI: 10.1007/s00431-018-03308-1  0.4
2019 Sun YR, Herrmann N, Scott CJM, Black SE, Swartz RH, Hopyan J, Lanctôt KL. Lithium Carbonate in a Poststroke Population: Exploratory Analyses of Neuroanatomical and Cognitive Outcomes. Journal of Clinical Psychopharmacology. 39: 67-71. PMID 30566418 DOI: 10.1097/JCP.0000000000000981  1
2018 Gallagher D, Kiss A, Lanctot KL, Herrmann N. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. The Journal of Clinical Psychiatry. 80. PMID 30549490 DOI: 10.4088/JCP.18m12331  1
2018 Mohammad D, Ellis C, Rau A, Rosenberg PB, Mintzer J, Ruthirakuhan M, Herrmann N, Lanctôt KL. Psychometric Properties of Apathy Scales in Dementia: A Systematic Review. Journal of Alzheimer's Disease : Jad. PMID 30400094 DOI: 10.3233/JAD-180485  0.6
2018 Saleem M, Herrmann N, Dinoff A, Mazereeuw G, Oh PI, Goldstein BI, Kiss A, Shammi P, Lanctôt KL. Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation. Psychosomatic Medicine. PMID 30383709 DOI: 10.1097/PSY.0000000000000651  1
2018 Rosen M, Chan P, Saleem M, Herrmann N, Adibfar A, Andreazza A, Oh PI, Lanctôt KL. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients. Psychiatry Research. 270: 219-224. PMID 30267986 DOI: 10.1016/j.psychres.2018.09.046  0.6
2018 Dinoff A, Herrmann N, Swardfager W, Gallagher D, Lanctôt KL. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis. Journal of Psychiatric Research. 105: 123-131. PMID 30219561 DOI: 10.1016/j.jpsychires.2018.08.021  0.6
2018 Mohammad D, Ellis C, Rau A, Ruthirakuhan M, Lanctôt KL, Herrmann N. Psychometric properties of apathy scales in Parkinson's disease: a systematic review. Neurodegenerative Disease Management. PMID 30040024 DOI: 10.2217/nmt-2018-0010  0.6
2018 Chan P, Saleem M, Herrmann N, Mielke MM, Haughey NJ, Oh PI, Kiss A, Lanctôt KL. Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study. Journal of Alzheimer's Disease : Jad. PMID 30010121 DOI: 10.3233/JAD-180030  1
2018 Chau SA, Herrmann N, Chung J, Eizenman M, Lanctôt KL. Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot Study. Canadian Geriatrics Journal : Cgj. 21: 139-142. PMID 29977428 DOI: 10.5770/cgj.21.291  0.6
2018 Gallagher D, Kiss A, Lanctot K, Herrmann N. Depression and Risk of Alzheimer's Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 29960668 DOI: 10.1016/j.jagp.2018.05.002  1
2018 Ruthirakuhan M, Lanctôt KL, Di Scipio M, Ahmed M, Herrmann N. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29940162 DOI: 10.1016/j.jalz.2018.04.013  0.6
2018 Fishman KN, Ashbaugh AR, Lanctôt KL, Cayley ML, Herrmann N, Murray BJ, Sicard M, Lien K, Sahlas DJ, Swartz RH. The Role of Apathy and Depression on Verbal Learning and Memory Performance After Stroke. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 29788381 DOI: 10.1093/arclin/acy044  0.6
2018 Chan P, Suridjan I, Mohammad D, Herrmann N, Mazereeuw G, Hillyer LM, Ma DWL, Oh PI, Lanctôt KL. Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease. Journal of the American Heart Association. 7. PMID 29730646 DOI: 10.1161/JAHA.117.008278  0.6
2018 Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL. Pharmacological interventions for apathy in Alzheimer's disease. The Cochrane Database of Systematic Reviews. 5: CD012197. PMID 29727467 DOI: 10.1002/14651858.CD012197.pub2  0.6
2018 Hawkins M, Schaffer A, Sinyor M, Nishikawa Y, Herrmann N, Lanctôt KL, Styra R, Pompili M, Huffman J. Suicide deaths by intentional self-poisoning in people with cardiovascular disease. General Hospital Psychiatry. 52: 41-47. PMID 29621659 DOI: 10.1016/j.genhosppsych.2018.03.005  0.6
2018 Middleton LE, Black SE, Herrmann N, Oh PI, Regan K, Lanctot KL. Centre- versus home-based exercise among people with mci and mild dementia: study protocol for a randomized parallel-group trial. Bmc Geriatrics. 18: 27. PMID 29370756 DOI: 10.1186/s12877-017-0684-0  1
2018 Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 19: 46. PMID 29347996 DOI: 10.1186/s13063-017-2406-5  0.6
2017 Sherman C, Ruthirakuhan M, Vieira D, Lanctôt KL, Herrmann N. Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia. Current Opinion in Psychiatry. PMID 29256923 DOI: 10.1097/YCO.0000000000000399  0.6
2017 Mazereeuw G, Herrmann N, Andreazza AC, Scola G, Ma DWL, Oh PI, Lanctôt KL. Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients. Cardiovascular Psychiatry and Neurology. 2017: 3674371. PMID 29230323 DOI: 10.1155/2017/3674371  0.6
2017 Dinoff A, Saleem M, Herrmann N, Mielke MM, Oh PI, Venkata SLV, Haughey NJ, Lanctôt KL. Plasma sphingolipids and depressive symptoms in coronary artery disease. Brain and Behavior. 7: e00836. PMID 29201542 DOI: 10.1002/brb3.836  0.6
2017 Khan MM, Herrmann N, Gallagher D, Gandell D, Fremes SE, Wijeysundera HC, Radhakrishnan S, Sun YR, Lanctôt KL. Cognitive Outcomes After Transcatheter Aortic Valve Implantation: A Metaanalysis. Journal of the American Geriatrics Society. PMID 29159840 DOI: 10.1111/jgs.15123  0.6
2017 Liu CS, Rau A, Gallagher D, Rajji TK, Lanctôt KL, Herrmann N. Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer's disease. Neurodegenerative Disease Management. PMID 29043928 DOI: 10.2217/nmt-2017-0021  0.6
2017 Fishman KN, Ashbaugh AR, Lanctôt KL, Cayley ML, Herrmann N, Murray BJ, Sicard M, Lien K, Sahlas DJ, Swartz RH. Apathy, not depressive symptoms, as a predictor of semantic and phonemic fluency task performance in stroke and transient ischemic attack. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 28911268 DOI: 10.1080/13803395.2017.1371282  0.6
2017 Sun YR, Herrmann N, Scott CJM, Black SE, Khan MM, Lanctôt KL. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis. Journal of Affective Disorders. 225: 599-606. PMID 28886501 DOI: 10.1016/j.jad.2017.08.078  1
2017 Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, Carvalho AF, Herrmann N. Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28794151 DOI: 10.1136/jnnp-2017-316201  0.6
2017 Edwards JD, Ramirez J, Callahan BL, Tobe SW, Oh P, Berezuk C, Lanctôt K, Swardfager W, Nestor S, Kiss A, Strother S, Black SE. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study. Journal of Alzheimer's Disease : Jad. PMID 28731439 DOI: 10.3233/JAD-170238  1
2017 Desmarais P, Lanctôt KL, Masellis M, Black SE, Herrmann N. Social inappropriateness in neurodegenerative disorders. International Psychogeriatrics. 1-11. PMID 28689508 DOI: 10.1017/S1041610217001260  1
2017 Mohammad D, Chan P, Bradley J, Lanctôt K, Herrmann N. Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert Opinion On Drug Safety. PMID 28678552 DOI: 10.1080/14740338.2017.1351540  0.6
2017 Köhler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanctôt KL, Carvalho AF. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Molecular Neurobiology. PMID 28612257 DOI: 10.1007/s12035-017-0632-1  0.6
2017 Suridjan I, Herrmann N, Adibfar A, Saleem M, Andreazza A, Oh PI, Lanctôt KL. Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 28505971 DOI: 10.3233/JAD-161248  0.6
2017 Dinoff A, Herrmann N, Swardfager W, Lanctôt KL. The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor (BDNF) in healthy adults: A meta-analysis. The European Journal of Neuroscience. PMID 28493624 DOI: 10.1111/ejn.13603  0.6
2017 Santiago C, Herrmann N, Swardfager W, Saleem M, Oh PI, Black SE, Bradley J, Lanctôt KL. Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation. International Journal of Geriatric Psychiatry. PMID 28474775 DOI: 10.1002/gps.4729  1
2017 Kapoor A, Lanctôt KL, Bayley M, Kiss A, Herrmann N, Murray BJ, Swartz RH. "Good Outcome" Isn't Good Enough: Cognitive Impairment, Depressive Symptoms, and Social Restrictions in Physically Recovered Stroke Patients. Stroke. PMID 28438907 DOI: 10.1161/STROKEAHA.117.016728  1
2017 Sherman C, Liu CS, Herrmann N, Lanctôt KL. Prevalence, neurobiology, and treatments for apathy in prodromal dementia. International Psychogeriatrics. 1-8. PMID 28416030 DOI: 10.1017/S1041610217000527  0.6
2017 Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Cohen A, Thorpe KE, Sicard MN, Lien K, Sahlas DJ, Herrmann N. The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics. Plos One. 12: e0174451. PMID 28376127 DOI: 10.1371/journal.pone.0174451  0.6
2017 Dinoff A, Herrmann N, Lanctôt KL. Ceramides and depression: A systematic review. Journal of Affective Disorders. 213: 35-43. PMID 28189963 DOI: 10.1016/j.jad.2017.02.008  0.6
2016 Gallagher D, Kiss A, Lanctot K, Herrmann N. Depression with inflammation: longitudinal analysis of a proposed depressive subtype in community dwelling older adults. International Journal of Geriatric Psychiatry. PMID 27911015 DOI: 10.1002/gps.4645  1
2016 Rej S, Saleem M, Herrmann N, Stefatos A, Rau A, Lanctôt KL. Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease. Neuropsychiatric Disease and Treatment. 12: 2913-2920. PMID 27877045 DOI: 10.2147/NDT.S115505  0.6
2016 Chau SA, Herrmann N, Sherman C, Chung J, Eizenman M, Kiss A, Lanctôt KL. Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients. Journal of Alzheimer's Disease : Jad. PMID 27834775 DOI: 10.3233/JAD-160641  1
2016 Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt K. Beyond Immunotherapy: New Approaches for Disease Modifying Treatments for Early Alzheimer's disease. Expert Opinion On Pharmacotherapy. PMID 27825018 DOI: 10.1080/14656566.2016.1258060  0.6
2016 Mazereeuw G, Herrmann N, Andreazza AC, Scola G, Wl Ma D, I Oh P, Lanctôt KL. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients. Brain, Behavior, and Immunity. PMID 27742581 DOI: 10.1016/j.bbi.2016.10.005  1
2016 Dinoff A, Herrmann N, Swardfager W, Liu CS, Sherman C, Chan S, Lanctôt KL. The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis. Plos One. 11: e0163037. PMID 27658238 DOI: 10.1371/journal.pone.0163037  0.6
2016 Manzoni P, Paes B, Lanctôt KL, DallʼAgnola A, Mitchell I, Calabrese S, Maule M, Girardi E, Harimoto T, Li A. Outcomes of Infants Receiving Palivizumab Prophylaxis for RSV in Canada and Italy: An International, Prospective, Cohort Study. The Pediatric Infectious Disease Journal. PMID 27649365 DOI: 10.1097/INF.0000000000001340  1
2016 Mazereeuw G, Lanctôt KL, Herrmann N. Dr Mazereeuw and Colleagues Reply. The Journal of Clinical Psychiatry. 77: e1006. PMID 27561143 DOI: 10.4088/JCP.16lr10666a  0.6
2016 Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A, Lanctôt KL. Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Psychopharmacology. PMID 27529771 DOI: 10.1097/JCP.0000000000000565  1
2016 Liu CS, Adibfar A, Herrmann N, Gallagher D, Lanctôt KL. Evidence for Inflammation-Associated Depression. Current Topics in Behavioral Neurosciences. PMID 27221622 DOI: 10.1007/7854_2016_2  0.6
2016 Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL. Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments. Current Alzheimer Research. PMID 27137221 DOI: 10.2174/1567205013666160502122933  0.6
2016 Swartz RH, Bayley M, Lanctôt KL, Murray BJ, Cayley ML, Lien K, Sicard MN, Thorpe KE, Dowlatshahi D, Mandzia JL, Casaubon LK, Saposnik G, Perez Y, Sahlas DJ, Herrmann N. Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screening. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27073189 DOI: 10.1177/1747493016641968  1
2016 Carvalho AF, Köhler CA, Brunoni AR, Miskowiak KW, Herrmann N, Lanctôt KL, Hyphantis TN, Quevedo J, Fernandes BS, Berk M. Bias in Peripheral Depression Biomarkers. Psychotherapy and Psychosomatics. 85: 81-90. PMID 26808272 DOI: 10.1159/000441457  1
2016 Swartz RH, Cayley ML, Lanctôt KL, Murray BJ, Smith EE, Sahlas DJ, Herrmann N, Cohen A, Thorpe KE. Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment Stroke. DOI: 10.1161/STROKEAHA.115.011036  1
2016 Hawkins M, Schaffer A, Reis C, Sinyor M, Herrmann N, Lanctôt KL. Suicide in males and females with cardiovascular disease and comorbid depression Journal of Affective Disorders. 197: 88-93. DOI: 10.1016/j.jad.2016.02.061  0.6
2016 Kirkham JG, Takwoingi Y, Quinn TJ, Rapoport M, Lanctôt KL, Maxwell CJ, Herrmann N, Gill SS, Rochon PA, Seitz DP. Depression rating scales for detection of major depression in people with dementia Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.CD012312  1
2015 Chau SA, Herrmann N, Eizenman M, Chung J, Lanctôt KL. Exploring Visual Selective Attention towards Novel Stimuli in Alzheimer's Disease Patients. Dementia and Geriatric Cognitive Disorders Extra. 5: 492-502. PMID 26955382 DOI: 10.1159/000442383  0.6
2015 O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N. Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials. The Journal of Clinical Psychiatry. 76: e1424-31. PMID 26646039 DOI: 10.4088/JCP.14r09237  0.6
2015 Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL. A meta-analysis of lipid peroxidation markers in major depression. Neuropsychiatric Disease and Treatment. 11: 2479-91. PMID 26491326 DOI: 10.2147/NDT.S89922  0.6
2015 Saleem M, Herrmann N, Swardfager W, Eisen R, Lanctôt KL. Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis. Journal of Alzheimer's Disease : Jad. 47: 669-79. PMID 26401702 DOI: 10.3233/JAD-150042  0.6
2015 Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SA, Lanctôt KL. Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study. Neuropsychiatric Disease and Treatment. 11: 2309-14. PMID 26379437 DOI: 10.2147/NDT.S87111  1
2015 Intzandt B, Black SE, Lanctôt KL, Herrmann N, Oh P, Middleton LE. Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment? Canadian Geriatrics Journal : Cgj. 18: 65-72. PMID 26180562 DOI: 10.5770/cgj.18.166  1
2015 Herrmann N, Harimoto T, Balshaw R, Lanctôt KL. Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID). Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 189-99. PMID 26174219 DOI: 10.1177/070674371506000406  0.6
2015 Eskes GA, Lanctôt KL, Herrmann N, Lindsay P, Bayley M, Bouvier L, Dawson D, Egi S, Gilchrist E, Green T, Gubitz G, Hill MD, Hopper T, Khan A, King A, et al. Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 26121596 DOI: 10.1111/ijs.12557  1
2015 Lai KS, Herrmann N, Saleem M, Lanctôt KL. Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review. Cardiovascular Psychiatry and Neurology. 2015: 209569. PMID 25785192 DOI: 10.1155/2015/209569  0.6
2015 Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. International Psychogeriatrics / Ipa. 27: 7-17. PMID 25311499 DOI: 10.1017/S1041610214001963  1
2015 MacIntosh BJ, Swardfager W, Robertson AD, Tchistiakova E, Saleem M, Oh PI, Herrmann N, Stefanovic B, Lanctôt KL. Regional cerebral arterial transit time hemodynamics correlate with vascular risk factors and cognitive function in men with coronary artery disease. Ajnr. American Journal of Neuroradiology. 36: 295-301. PMID 25147198 DOI: 10.3174/ajnr.A4094  1
2015 Swardfager W, Herrmann N, Mazereeuw G, Lanctôt KL. Reply to: Serum zinc and the risk of depression in men: observations from a 20-year follow-up study. Biological Psychiatry. 77: e13-4. PMID 25034951 DOI: 10.1016/j.biopsych.2014.06.006  0.6
2014 Behl P, Edwards JD, Kiss A, Lanctot KL, Streiner DL, Black SE, Stuss DT. Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study. Alzheimer's Research & Therapy. 6: 48. PMID 25484926 DOI: 10.1186/alzrt280  1
2014 Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL. Kynurenine and depressive symptoms in a poststroke population. Neuropsychiatric Disease and Treatment. 10: 1827-35. PMID 25285006 DOI: 10.2147/NDT.S65740  1
2014 Mazereeuw G, Herrmann N, Xu H, Figeys D, Oh PI, Bennett SA, Lanctôt KL. Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. Journal of Neuroinflammation. 11: 119. PMID 24996486 DOI: 10.1186/1742-2094-11-119  1
2014 Yi H, Lanctôt KL, Bont L, Bloemers BL, Weijerman M, Broers C, Li A, Kiss A, Mitchell I, Paes B. Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study. Pediatrics. 133: 1031-7. PMID 24799541 DOI: 10.1542/peds.2013-3916  1
2014 MacIntosh BJ, Swardfager W, Crane DE, Ranepura N, Saleem M, Oh PI, Stefanovic B, Herrmann N, Lanctôt KL. Cardiopulmonary fitness correlates with regional cerebral grey matter perfusion and density in men with coronary artery disease. Plos One. 9: e91251. PMID 24622163 DOI: 10.1371/journal.pone.0091251  1
2014 Lanctôt KL, Chau SA, Herrmann N, Drye LT, Rosenberg PB, Scherer RW, Black SE, Vaidya V, Bachman DL, Mintzer JE. Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. International Psychogeriatrics / Ipa. 26: 239-46. PMID 24169147 DOI: 10.1017/S1041610213001762  1
2013 Herrmann N, Lanctôt KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer's Research & Therapy. 5: S5. PMID 24565367 DOI: 10.1186/alzrt201  1
2013 Saleem M, Ratnam Bandaru VV, Herrmann N, Swardfager W, Mielke MM, Oh PI, Shammi P, Kiss A, Haughey NJ, Rovinski R, Lanctôt KL. Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study. Bmc Geriatrics. 13: 135. PMID 24330446 DOI: 10.1186/1471-2318-13-135  1
2013 Benhabib H, Lanctôt KL, Eryavec GM, Li A, Herrmann N. Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer's Disease. Canadian Geriatrics Journal : Cgj. 16: 180-5. PMID 24278094 DOI: 10.5770/cgj.16.78  0.6
2013 Paes B, Mitchell I, Li A, Harimoto T, Lanctôt KL. Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries. Clinical & Developmental Immunology. 2013: 917068. PMID 23861694 DOI: 10.1155/2013/917068  0.52
2013 Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biological Psychiatry. 74: 872-8. PMID 23806573 DOI: 10.1016/j.biopsych.2013.05.008  0.6
2013 Mazereeuw G, Herrmann N, Bennett SA, Swardfager W, Xu H, Valenzuela N, Fai S, Lanctôt KL. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. Neuroscience and Biobehavioral Reviews. 37: 1611-21. PMID 23800745 DOI: 10.1016/j.neubiorev.2013.06.010  1
2013 Swardfager W, Herrmann N, McIntyre RS, Mazereeuw G, Goldberger K, Cha DS, Schwartz Y, Lanctôt KL. Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience and Biobehavioral Reviews. 37: 911-29. PMID 23567517 DOI: 10.1016/j.neubiorev.2013.03.018  0.6
2013 Drye LT, Scherer RW, Lanctôt KL, Rosenberg PB, Herrmann N, Bachman D, Mintzer JE. Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET). The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 549-59. PMID 23567407 DOI: 10.1097/JGP.0b013e31824afba8  0.6
2013 Saleem M, Herrmann N, Swardfager W, Oh PI, Shammi P, Koren G, Van Uum S, Kiss A, Lanctôt KL. Higher cortisol predicts less improvement in verbal memory performance after cardiac rehabilitation in patients with coronary artery disease. Cardiovascular Psychiatry and Neurology. 2013: 340342. PMID 23401745 DOI: 10.1155/2013/340342  1
2013 Swardfager W, Winer DA, Herrmann N, Winer S, Lanctôt KL. Interleukin-17 in post-stroke neurodegeneration. Neuroscience and Biobehavioral Reviews. 37: 436-47. PMID 23370232 DOI: 10.1016/j.neubiorev.2013.01.021  0.6
2012 Swardfager W, Herrmann N, Cornish S, Mazereeuw G, Marzolini S, Sham L, Lanctôt KL. Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. American Heart Journal. 163: 666-76.e1-3. PMID 22520533 DOI: 10.1016/j.ahj.2011.12.017  0.6
2012 Mazereeuw G, Lanctôt KL, Chau SA, Swardfager W, Herrmann N. Effects of ω-3 fatty acids on cognitive performance: a meta-analysis. Neurobiology of Aging. 33: 1482.e17-29. PMID 22305186 DOI: 10.1016/j.neurobiolaging.2011.12.014  0.6
2012 Herrmann N, Black SE, Chow T, Cappell J, Tang-Wai DF, Lanctôt KL. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 789-97. PMID 21878805 DOI: 10.1097/JGP.0b013e31823033f3  1
2011 Tennen G, Herrmann N, Black SE, Levy KS, Cappell J, Li A, Lanctôt KL. Are vascular risk factors associated with post-stroke depressive symptoms? Journal of Geriatric Psychiatry and Neurology. 24: 215-21. PMID 22228828 DOI: 10.1177/0891988711422526  1
2011 Swardfager W, Herrmann N, Marzolini S, Oh PI, Saleem M, Shammi P, Kiss A, Cappell J, Lanctôt KL. Verbal memory performance and completion of cardiac rehabilitation in patients with coronary artery disease. Psychosomatic Medicine. 73: 580-7. PMID 21807866 DOI: 10.1097/PSY.0b013e318227fff9  1
2011 Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Canadian Respiratory Journal. 18: e10-9. PMID 21499597 DOI: 10.1155/2011/493056  1
2011 Smart KA, Herrmann N, Lanctôt KL. Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research. Journal of Geriatric Psychiatry and Neurology. 24: 67-72. PMID 21460341 DOI: 10.1177/0891988711402347  0.6
2011 Gold AB, Herrmann N, Swardfager W, Black SE, Aviv RI, Tennen G, Kiss A, Lanctôt KL. The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. Journal of Neuroinflammation. 8: 17. PMID 21324164 DOI: 10.1186/1742-2094-8-17  1
2011 Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, Oh PI, Lanctôt KL. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease. The Journal of Clinical Psychiatry. 72: 1181-8. PMID 21208573 DOI: 10.4088/JCP.09m05810blu  1
2011 Herrmann N, Black SE, Li A, Lanctôt KL. Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts. International Psychogeriatrics / Ipa. 23: 539-45. PMID 20849673 DOI: 10.1017/S1041610210001535  1
2011 Mitchell RA, Herrmann N, Lanctôt KL. The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease. Cns Neuroscience & Therapeutics. 17: 411-27. PMID 20560994 DOI: 10.1111/j.1755-5949.2010.00161.x  0.6
2011 Grupp SG, Greenberg ML, Ray JG, Busto U, Lanctôt KL, Nulman I, Koren G. Pediatric cancer rates after universal folic acid flour fortification in Ontario. Journal of Clinical Pharmacology. 51: 60-5. PMID 20457589 DOI: 10.1177/0091270010365553  1
2010 Herrmann N, Tam DY, Balshaw R, Sambrook R, Lesnikova N, Lanctôt KL. The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 768-75. PMID 21172097 DOI: 10.1177/070674371005501204  0.6
2010 Cappell J, Herrmann N, Cornish S, Lanctôt KL. The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease. Cns Drugs. 24: 909-27. PMID 20932064 DOI: 10.2165/11539530-000000000-00000  1
2010 Swardfager W, Lanctôt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry. 68: 930-41. PMID 20692646 DOI: 10.1016/j.biopsych.2010.06.012  0.48
2010 Swardfager W, Herrmann N, Marzolini S, Saleem M, Kiss A, Shammi P, Oh PI, Lanctôt KL. Cardiopulmonary fitness is associated with cognitive performance in patients with coronary artery disease. Journal of the American Geriatrics Society. 58: 1519-25. PMID 20646102 DOI: 10.1111/j.1532-5415.2010.02966.x  1
2010 Rothenburg LS, Herrmann N, Swardfager W, Black SE, Tennen G, Kiss A, Gladstone DJ, Ween J, Snaiderman A, Lanctôt KL. The relationship between inflammatory markers and post stroke cognitive impairment. Journal of Geriatric Psychiatry and Neurology. 23: 199-205. PMID 20601647 DOI: 10.1177/0891988710373598  1
2010 Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury. The Journal of Clinical Psychiatry. 71: 1125-30. PMID 20441723 DOI: 10.4088/JCP.09m05086blu  1
2010 Dowlati Y, Herrmann N, Swardfager WL, Reim EK, Lanctôt KL. Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 55: 91-9. PMID 20181304 DOI: 10.1177/070674371005500205  0.6
2010 Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. The Journal of Clinical Psychiatry. 71: 270-9. PMID 20122371 DOI: 10.4088/JCP.08r04516blu  1
2010 Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biological Psychiatry. 67: 446-57. PMID 20015486 DOI: 10.1016/j.biopsych.2009.09.033  0.6
2009 Lanctôt KL, Hsiung GY, Feldman HH, Masoud ST, Sham L, Herrmann N. Assessing the validity of deriving clinical dementia rating (CDR) global scores from independently-obtained functional rating scale (FRS) scores in vascular dementia with and without Alzheimer's disease. International Journal of Geriatric Psychiatry. 24: 1174-6. PMID 19768698 DOI: 10.1002/gps.2273  0.6
2009 Herrmann N, Rapoport MJ, Rajaram RD, Chan F, Kiss A, Ma AK, Feinstein A, McCullagh S, Lanctôt KL. Factor analysis of the rivermead post-concussion symptoms questionnaire in mild-to-moderate traumatic brain injury patients Journal of Neuropsychiatry and Clinical Neurosciences. 21: 181-188. PMID 19622689 DOI: 10.1176/jnp.2009.21.2.181  1
2009 Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctôt KL. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. Psychoneuroendocrinology. 34: 1560-6. PMID 19540675 DOI: 10.1016/j.psyneuen.2009.05.019  1
2009 Rapoport MJ, Lanctôt KL, Streiner DL, Bédard M, Vingilis E, Murray B, Schaffer A, Shulman KI, Herrmann N. Benzodiazepine use and driving: a meta-analysis. The Journal of Clinical Psychiatry. 70: 663-73. PMID 19389334 DOI: 10.4088/JCP.08m04325  1
2009 Ismail Z, Herrmann N, Francis PL, Rothenburg LS, Lobaugh NJ, Leibovitch FS, Black SE, Lanctôt KL. A SPECT study of sleep disturbance and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 27: 254-9. PMID 19246910 DOI: 10.1159/000203889  1
2009 Lanctót KL, Rajaram RD, Herrmann N. Therapy for Alzheimer's disease: How effective are current treatments? Therapeutic Advances in Neurological Disorders. 2: 163-180. DOI: 10.1177/1756285609102724  1
2008 Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 179: 1019-26. PMID 18981443 DOI: 10.1503/cmaj.081103  1
2008 Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 179: 787-93. PMID 18838454 DOI: 10.1503/cmaj.070803  1
2008 Behl P, Lanctôt KL, Streiner DL, Black SE. The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort. International Psychogeriatrics / Ipa. 20: 1141-59. PMID 18606043 DOI: 10.1017/S1041610208007540  1
2008 Lanctôt KL, Herrmann N, Black SE, Ryan M, Rothenburg LS, Liu BA, Busto UE. Apathy associated with Alzheimer disease: use of dextroamphetamine challenge. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 551-7. PMID 18591575 DOI: 10.1097/JGP.0b013e318170a6d1  1
2008 Lanctôt KL, Herrmann N, Rothenburg LS. Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels. Experimental Neurology. 212: 251-4. PMID 18544454 DOI: 10.1016/j.expneurol.2008.04.031  0.6
2008 Ismail Z, Herrmann N, Rothenburg LS, Cotter A, Leibovitch FS, Rafi-Tari S, Black SE, Lanctôt KL. A functional neuroimaging study of appetite loss in Alzheimer's disease. Journal of the Neurological Sciences. 271: 97-103. PMID 18495162 DOI: 10.1016/j.jns.2008.03.023  1
2008 Herrmann N, Rothenburg LS, Black SE, Ryan M, Liu BA, Busto UE, Lanctôt KL. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge. Journal of Clinical Psychopharmacology. 28: 296-301. PMID 18480686 DOI: 10.1097/JCP.0b013e318172b479  1
2008 Chan F, Lanctôt KL, Feinstein A, Herrmann N, Strauss J, Sicard T, Kennedy JL, McCullagh S, Rapoport MJ. The serotonin transporter polymorphisms and major depression following traumatic brain injury. Brain Injury. 22: 471-9. PMID 18465388 DOI: 10.1080/02699050802084886  0.6
2008 Swardfager W, Herrmann N, Dowlati Y, Oh P, Kiss A, Lanctôt KL. Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease. Journal of Rehabilitation Medicine. 40: 213-8. PMID 18292924 DOI: 10.2340/16501977-0151  1
2007 Lanctôt KL, Hussey DF, Herrmann N, Black SE, Rusjan PM, Wilson AA, Houle S, Kozloff N, Verhoeff NP, Kapur S. A positron emission tomography study of 5-hydroxytryptamine-1A receptors in Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 15: 888-98. PMID 17567932 DOI: 10.1097/JGP.0b013e3180488325  1
2007 Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Archives of Neurology. 64: 266-72. PMID 17296844 DOI: 10.1001/archneur.64.2.266  1
2007 Herrmann N, Lanctôt KL, Rothenburg LS, Eryavec G. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 23: 116-9. PMID 17148938 DOI: 10.1159/000097757  0.6
2007 Lanctôt KL, Herrmann N, Rothenburg L, Eryavec G. Behavioral correlates of GABAergic disruption in Alzheimer's disease. International Psychogeriatrics / Ipa. 19: 151-8. PMID 16870038 DOI: 10.1017/S1041610206003899  0.6
2006 Herrmann N, Lanctôt KL, Sambrook R, Lesnikova N, Hébert R, McCracken P, Robillard A, Nguyen E. The contribution of neuropsychiatric symptoms to the cost of dementia care. International Journal of Geriatric Psychiatry. 21: 972-6. PMID 16955429 DOI: 10.1002/gps.1594  1
2005 Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Bmj (Clinical Research Ed.). 331: 1169. PMID 16284208 DOI: 10.1136/bmj.38623.768588.47  1
2004 Herrmann N, Lanctôt KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia Journal of Neuropsychiatry and Clinical Neurosciences. 16: 261-276. PMID 15377733 DOI: 10.1176/JNP.16.3.261  1
2004 Lanctôt KL, Herrmaan N, Mazzotta P, Khan LR, Ingber N. GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioral and psychological symptoms of dementia Canadian Journal of Psychiatry. 49: 439-453. PMID 15362248 DOI: 10.1177/070674370404900705  1
2004 Herrmann N, Lanctôt KL, Eryavec G, Khan LR. Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients Journal of Psychopharmacology. 18: 215-220. PMID 15260910 DOI: 10.1177/0269881104042625  1
2004 Herrmann N, Lanctôt KL, Eryavec G, Van Reekum R, Khan LR. Growth hormone response to clonidine predicts aggression in Alzheimer's disease Psychoneuroendocrinology. 29: 1192-1197. PMID 15219643 DOI: 10.1016/j.psyneuen.2004.02.001  1
2002 Dergal JM, Gold JL, Laxer DA, Lee MS, Binns MA, Lanctôt KL, Freedman M, Rochon PA. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs & Aging. 19: 879-86. PMID 12428996 DOI: 10.2165/00002512-200219110-00005  1
2002 Oh PI, Lanctôt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P. Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes. The Pediatric Infectious Disease Journal. 21: 512-8. PMID 12182374 DOI: 10.1097/00006454-200206000-00007  1
2002 Schaffer A, Levitt AJ, Hershkop SK, Oh P, MacDonald C, Lanctot K. Utility scores of symptom profiles in major depression. Psychiatry Research. 110: 189-97. PMID 12057830 DOI: 10.1016/S0165-1781(02)00097-5  1
2001 Rojas-Fernandez CH, Lanctôt KL, Allen DD, MacKnight C. Pharmacotherapy of behavioral and psychological symptoms of dementia: Time for a different paradigm? Pharmacotherapy. 21: 74-102. PMID 11191740 DOI: 10.1592/phco.21.1.74.34437  1
2001 Gold JL, Laxer DA, Dergal JM, Lanctôt KL, Rochon PA. Herbal-drug therapy interactions: a focus on dementia. Current Opinion in Clinical Nutrition and Metabolic Care. 4: 29-34. PMID 11122556 DOI: 10.1097/00075197-200101000-00006  1
1998 Lanctôt KL, Best TS, Mittmann N, Liu BA, Oh PI, Einarson TR, Naranjo CA. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia Journal of Clinical Psychiatry. 59: 550-561. PMID 9818639 DOI: 10.4088/JCP.V59N1010  1
1997 Iskedjian M, Trakas K, Bradley CA, Addis A, Lanctôt K, Kruk D, Ilersich AL, Einarson TR. (Quality assessment of economic evaluations published in ParmacoEconomics the first four years (1992 to 1995) Pharmacoeconomics. 12: 685-694. PMID 10175980 DOI: 10.2165/00019053-199712060-00008  1
1995 Bradley CA, Iskedjian M, Lanctot KL, Mittmann N, Simone C, St Pierre E, Miller E, Blatman B, Chabursky B, Einarson TR. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals Annals of Pharmacotherapy. 29: 681-689. PMID 8520080 DOI: 10.1177/106002809502907-805  1
1993 Ruiz I, Offermanns J, Lanctot KL, Busto U. Comparative study on benzodiazepine use in Canada and Chile Journal of Clinical Pharmacology. 33: 124-129. PMID 8095053  1
Show low-probability matches.